Yoshihiro Ohue

Title: Yoshihiro Ohue: Innovator in Cancer Treatment Examination Methods

Introduction

Yoshihiro Ohue is a notable inventor based in New York, NY (US). He has made significant contributions to the field of cancer treatment through his innovative examination methods. His work focuses on predicting the effects of cancer treatments by detecting specific antibodies.

Latest Patents

Yoshihiro Ohue holds a patent for an "Examination method for prediction of effect of treatment of cancer based on detection of cancer/testis antibodies." This patent aims to provide a novel examination method for assessing cancer treatment effects, as well as a screening method for peptides used in cancer vaccines. The invention includes detecting antibodies against cancer/testis antigens or anti-p53 antibodies in samples. Notably, it is suitable for detecting anti-XAGE1 antibodies (IgG and/or IgA) or anti-NY-ESO-1 antibodies (IgG). Additionally, the patent introduces a novel peptide and composition designed to induce immune responses against cancer.

Career Highlights

Yoshihiro Ohue is associated with the Kawasaki Gakuen Educational Foundation, where he continues to advance research in cancer treatment methodologies. His dedication to innovation in this critical field has positioned him as a key figure in medical research.

Collaborations

Yoshihiro has collaborated with esteemed colleagues, including Mikio Oka and Eiichi Nakayama, to further enhance the impact of his research and inventions.

Conclusion

Yoshihiro Ohue's contributions to cancer treatment through his patented examination methods highlight his commitment to improving patient outcomes. His innovative approaches are paving the way for advancements in cancer therapy.